RSJ Gradus focuses on investments in the area of Life Sciences; mainly research aimed at improving and prolonging human life. The sub-fund of RSJ invests into newly or recently established technology companies and actively seeks out startups with revolutionary therapeutic methods. Main emphasis is on areas that current health-care approaches failed to sufficiently resolve.
RSJ Gradus invests exclusively into areas where we have deep knowledge available and which lie on the margins of interest of for traditional risk-capital funds (venture funds). We are long-term investors, who closely collaborate with management of the companies in which we invest. We prefer the role of a lead investor in our projects.
Potential for future sale of the company.
Clearly defined clinical goals, possibly in synergy with other companies within the portfolio.
Focus on USA and EU.